top of page

CanVIG-UK Gene Specific Recommendations

*NEW GUIDANCE*

Version 1.0

CanVIG-UK interim gene specific recommendations for PTEN variants.

Approved: 1st November 2022

*NEW GUIDANCE*

Version 1.17

CanVIG-UK gene specific recommendations for BRCA1/BRCA2 variants.

Approved: 27th September 2022

 

Previous BRCA1/BRCA2 guidance: Version 1.16, Version 1.15, Version 1.14, Version 1.12, Version 1.10

CanVIG-UK gene specific recommendations for ATM variants can be found on the gene-specific summary page on CanVar-UK:

https://canvaruk.org/ATM/genespecview 

Version 1.3

CanVIG-UK gene specific recommendations for SDHB and SDHD variants.

Approved: 23rd March 2022

 

Version 1.5

CanVIG-UK gene specific recommendations for MMR gene variants.

Approved: 25th May 2022

Previous MMR Guidance: Version 1.3, Version 1.4

Version 1.0

CanVIG-UK gene specific recommendations for CHEK2 variants.

Approved: 24th June 2022

Version 1.5

CanVIG-UK gene specific recommendations for TP53 variants.

Approved: 4th March 2022

Previous TP53 guidance: Version 1.4

bottom of page